Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified Health Condition 2: null- Patients would be suffering from lung disease and planned for thoracoscopy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: weight between 30 and 80 kg ASA- I-III patients undergoing medical thoracoscopy under conscious sedation Informed written consent
Exclusion criteria
Exclusion criteria: a)Intubated patients b)patients with a known allergy or intolerance to midazolam, fentanyl and dexmedetomidine c)pregnant or nursing women d)patients with a mental disorder preventing appropriate judgment concerning study participation e)hypersensitivity or allergy to the study drugs f)uncontrolled hypertension (uncontrolled blood pressure >140/90 mmHg) g)major abnormalities of liver function, ischemic heart disease and severe respiratory disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effects of dexmedetomidine and midazolam in conscious sedation for patients undergoing medical thoracoscopy on pulmonologist and patient satisfaction.Timepoint: Pulmonologist satisfaction at the end of procedure and patient satisfaction at 2 hours after the procedure will be evaluated. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the effects of dexmedetomidine and midazolam in conscious sedation for patients undergoing medical thoracoscopy on hemodynamic variables.Timepoint: during the procedure | — |
Countries
India
Contacts
AIIMS